Trial
NCT00676559
Combined aPproach to Treatment Using Ranibizumab and Efalizumab for Diabetic Macular Edema Study: The CAPTURE DME Study
Phase IWITHDRAWNSAFETYConfidence: HIGH
Sponsor
Johns Hopkins University
Collaborators
Juvenile Diabetes Research Foundation; Genentech, Inc.
Condition
Diabetic Macular Edema
Intervention
Efalizumab
Why stopped
Unrelated serious adverse events involving one of the proposed medications
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-08-26